Revvity, Inc. (0KHE.L)
| Previous close | 101.45 |
| Open | 101.92 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 100.98 - 102.56 |
| 52-week range | 79.50 - 138.90 |
| Volume | |
| Avg. volume | 4,427 |
| Market cap | 113.082M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | 0.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Revvity Board Declares Quarterly Dividend
WALTHAM, Mass., April 25, 2024--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024.
- Business Wire
Revvity to Present at BofA Securities 2024 Health Care Conference
WALTHAM, Mass., April 25, 2024--Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV.
- Business Wire
Revvity Unveils a New Era of Automated Tuberculosis Testing
WALTHAM, Mass., April 24, 2024--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.
